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 Introduction 
 Today, a wide range of highly efficient topical anti-
septics is in use, and new antiseptic substances espe-
cially for wound care are being continuously developed 
 [1–4] . The first steps of wound bed preparation include 
wound debridement, in order to reduce the amount of 
necrotic tissue (‘cellular burden’), and thereafter anti-
septic measures to reduce the formation of biofilms 
within the wound (‘bioburden’) and the wound edge  [5] . 
The spectrum of microbes within the wound environ-
ment entails a variety of bacteria and fungi, and the 
composition of the biofilm is steadily shifting  [6, 7] . 
Modern antiseptics target a wide spectrum of bacteria 
and fungi exerting only minimal cytotoxic effects espe-
cially on the highly proliferating wound tissue  [8] . Poli-
hexanides and octenidine dihydrochloride meet these 
criteria to a certain extent  [9] and are commonly used 
for wound treatment. In addition to chemical antiseptic 
treatments, physical antiseptic procedures such as tis-
sue-tolerable plasma (TTP) are being evaluated for their 
benefit to wound care. TTP is loosely described as an 
electrically neutral medium of positive and negative 
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 Abstract 
 Colonization and infection of wounds represent a major rea-
son for the impairment of tissue repair. Recently, it has been 
reported that tissue-tolerable plasma (TTP) is highly efficient 
in the reduction of the bacterial load of the skin. In the pres-
ent study, the antiseptic efficacy of TTP was compared to 
that of octenidine hydrochloride with 2-phenoxyethanol. 
Both antiseptic methods proved to be highly efficient. Cuta-
neous treatment of the skin with octenidine hydrochloride 
and 2-phenoxyethanol leads to a 99% elimination of the 
bacteria, and 74% elimination is achieved by TTP treatment. 
Technical challenges with an early prototype TTP device 
could be held responsible for the slightly reduced antiseptic 
properties of TTP, compared to a standard antiseptic solu-
tion, since the manual treatment of the skin surface with a 
small beam of the TTP device might have led to an incom-
plete coverage of the treated area. 
 Copyright © 2012 S. Karger AG, Basel 
 Received: September 1, 2011 
 Accepted after revision: December 6, 2011 
 Published online: February 1, 2012 
 Dr. Alexa Patzelt 
 Center of Experimental and Applied Cutaneous Physiology
Department of Dermatology,  Charité – Universitätsmedizin Berlin, Charitéplatz 1 
 DE–10117 Berlin (Germany) 
 Tel. +49 30 450 518 106, E-Mail alexa.patzelt   @   charite.de 
 © 2012 S. Karger AG, Basel
1660–5527/12/0252–0100/$38.00/0 
 Accessible online at:
www.karger.com/spp 
 Plasma in vivo Study Skin Pharmacol Physiol 2012;25:100–106 101
particles and represents another state of aggregation of 
matter next to the solid, liquid and gas state of matter 
 [10–13] . Aside from these preliminary results of the us-
age of TTP for wound antisepsis  [11, 14, 15] , this technol-
ogy is also thought to be applicable for antisepsis of in-
tact skin  [12, 13] . Recently, TTP produced by an electri-
cal discharge in a plasma jet has been reported to 
efficiently reduce bacterial colonization on human skin 
 [16] . However, these investigations were mainly per-
formed in vitro using cell culture assays or tissue har-
vested from animals as a model  [17] . The first in vivo 
study was published by Isbary et al. [15] , investigating 
the effects of plasma treatment on lesions of patients suf-
fering from Hailey-Hailey disease. Risk analysis of the 
application of TTP for antiseptic treatment in dermatol-
ogy found skin damage by TTP-related UV radiation to 
be negligible. Moreover, thermal damage by TTP was 
minimal and related only to the first superficial cell lay-
ers of the stratum corneum  [17] . Based on these first risk 
assessments, approval by the Ethics Committee had 
been obtained to use the TTP technology for an in vivo 
study on antiseptic efficacy. In the present study, the ef-
ficacy of a widely used antiseptic solution, a combina-
tion of octenidine dihydrochloride and 2-phenoxyetha-
nol (Octenisept  ), and the TTP was compared in vivo 
on healthy human skin. In addition, the influence of an-
tiseptic treatment on the skin barrier and on the anti-
oxidative network of the human skin was evaluated.
 Subjects and Methods 
 Volunteers 
 For the investigations, 10 (6 male and 4 female) healthy volun-
teers aged between 26 and 42 years were recruited at the Depart-
ment of Dermatology, Charité – Universitätsmedizin Berlin, Ger-
many. The approval of the Ethics Committee to conduct the study 
had been obtained before the start of the investigations (EA1/
010/10).
 Antiseptic Treatments and Technical Equipment 
 In all experiments, an antiseptic containing 0.1% octenidine 
dihydrochloride and 2% 2-phenoxyethanol as active ingredients 
(Octenisept, Schuelke & Mayr GmbH, Norderstedt, Germany) 
was used.
 Plasma Jet Pen 
 The low-temperature plasma used in the present study was 
generated by the plasma jet kinpen 09  developed by the Leibniz 
Institute for Plasma Science and Technology, Greifswald, Germa-
ny, in cooperation with Neoplas GmbH, Greifswald, Germany. A 
detailed description of the plasma jet is given by Weltmann et al. 
 [16]  and Hubner et al.  [18] . The plasma jet consists of a base station 
including the power supply and the control unit, together with a 
handpiece containing the gas flow and the electrical discharge 
system. The discharge system was operated with argon, applied in 
the pulsed mode, with the pulses being generated at a frequency 
of 1.82 MHz.
 The plasma stream had a length of approximately 10 mm; the 
plasma-tissue interaction zone was approximately 1 mm in diam-
eter. A photo illustrating the action of the plasma stream on the 
skin surface is shown in  figure 1 .
 Analysis of the Skin Barrier by in vivo Laser Scanning 
Microscopy 
 Lademann et al.  [19] demonstrated that in vivo laser scanning 
microscopy (LSM) is well suited for the analysis of the barrier 
properties of the human skin. In the present study, the in vivo 
LSM Stratum (Optilas Ltd., Melbourne, Australia) was used for 
analyzing the structural changes of the uppermost layers of the 
skin – the stratum corneum –, which represents the skin barrier 
to the outer environment. A detailed description of the laser scan-
ning microscope is provided by Meyer et al.  [20] . The system con-
sists of a base station and a handpiece. Accommodating the argon 
laser unit (  = 488 nm), the power supply unit, the spectrometer 
and the control unit, the base is connected to the handpiece by 
optical fibers. The handpiece contains the optical imaging and 
focus control unit. The skin area analyzed by this LSM was 250 
 ! 250   m in size.
 Determination of Antioxidants in the Human Skin 
 A resonance Raman spectrometer developed for the detection 
of carotenoids in the human skin was used to analyze the influ-
ence of the skin treatment on the antioxidative system of the hu-
man skin with both antiseptic methods  [21] . The Raman system 
consisted of a base accommodating the Ar laser (  = 488 nm) and 
the spectrometer with the detector unit. The base is connected by 
optical fibers to the handpiece containing the optical imaging sys-
tem and the focal control unit. Using this system, the concentra-
tion of the carotenoids in the skin could be detected up to a depth 
 Fig. 1. Action of the plasma stream on the skin surface. 
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of 150   m. The measuring spot on the skin was 8 mm in diameter. 
A detailed description of the measuring system is provided by 
Darvin et al.  [22, 23] .
 Treatment of the Cutaneous Test Sites 
 The investigations were carried out on the right and left fore-
arms of the volunteers. On each forearm two skin areas of 4  ! 4 
cm in size were marked. One of these two skin areas on each arm 
was left untreated, whilst the other area was treated with octeni-
dine dihydrochloride/2-phenoxyethanol solution on one forearm 
and with TTP on the other. The application areas were random-
ized for each volunteer. Using the spray applicator, the octenidine 
dihydrochloride/2-phenoxyethanol solution was applied in the 
same manner as in the operating room for antiseptic treatment of 
the skin. The amount of octenidine dihydrochloride/2-phenoxy-
ethanol solution applied was sufficient to ensure that the skin sur-
face was completely and sufficiently covered. After 15 min, when 
the octenidine dihydrochloride/2-phenoxyethanol solution had 
completely evaporated, the bacterial colonization of the treated 
skin surface was investigated. The corresponding skin area on the 
other forearm was treated with TTP. For this purpose, the plasma 
beam was moved at an average velocity of 10 mm/s. This corre-
sponds to the optimum moving velocity of the plasma previously 
reported  [12] . In order to prevent residues of surviving bacteria on 
the untreated skin areas, the plasma beam was moved homoge-
neously over the entire skin area.
 Harvesting and Culture of Bacteria 
 Immediately after the plasma treatment or 15 min after the 
treatment with octenidine dihydrochloride/2-phenoxyethanol 
solution, the amount of bacteria on the skin surface was deter-
mined in accordance with the protocol of Williamson and Klig-
man  [24] . Using a sterile stainless-steel ring of 20 mm in diameter, 
1 ml of a basic solution consisting of 50% of a phosphate buffer 
solution (Dulbecco’s PBS; Laboratory GmbH, Graz, Austria) and 
50% of egg yolk were applied onto each skin area, which were 
dropped inside the ring in order to neutralize the antiseptic effi-
cacy of the octenidine dihydrochloride/2-phenoxyethanol solu-
tion. The neutralization was validated in separate tests according 
to EN 1040  [25] . The solution was distributed homogeneously in-
side the ring with a sterile applicator. The contact time of the ba-
sic solution with the tissue was 1 min. Subsequently, 0.5 ml of the 
supernatant was removed with a pipette and diluted with 4.5 ml 
basic solution (diluted solution 1: 10). The solution was shaken for 
30 s in a test tube shaker in order to obtain a homogeneous mix-
ture. 0.5 ml of the solution was applied to an agar plate (Columbia 
Blood type, Merck AG, Darmstadt, Germany) for bacterial 
growth. The agar plates, used for the microbiological part of the 
study, contained a highly nutritious, general-purpose medium for 
the isolation and cultivation of nonfastidious and fastidious mi-
croorganisms of the Columbia Blood type.
 The agar plate was kept in an incubator for 24 h at a tempera-
ture of 36   °   C. After 24 h, the agar plates were photographed and 
the numbers of colonies on each plate were determined by count 
and expressed as colony-forming units (CFU)/test field.
 To correct for the interindividual changes in bacterial counts, 
the initial number of CFU on the untreated areas of the corre-
sponding arms of each volunteer was standardized to 100%. The 
number of CFU determined after either skin antisepsis with oc-
tenidine dihydrochloride/2-phenoxyethanol solution or TTP was 
correlated to the respective initial value of the untreated skin, and 
the elimination of bacteria was expressed in percentage for each 
individual volunteer. Based on these values the overall elimina-
tion of bacteria and standard deviations were calculated for both 
treatments.
 Statistics 
 For statistical analysis, mean values and standard deviations 
were calculated. For further statistical analysis, the software pro-
gram SPSS  18.0 was applied. The Wilcoxon test was utilized to 
compare the numbers of bacterial colonies after different treat-
ment modes affording a significance p  ! 0.05.
 Results 
 Antiseptic Efficacy 
 The number of bacterial CFU detected on the un-
treated skin test sites showed large interindividual dif-
ferences from 16 to 601 CFU/test field. One volunteer 
exhibited an extremely high number of CFU and was 
therefore excluded from the study. The following results 
are related to the remaining 9 volunteers. On all test sites 
an average of 202.5  8 174.2 CFU was found before ei-
ther of the treatments. Because of the large interindi-
viduality, the initial number of CFU on the untreated 
areas of the corresponding arms of each volunteer was 
standardized to 100%.
 As demonstrated in  figure 2 , after treatment with oc-
tenidine dihydrochloride/2-phenoxyethanol solution, a 
99  8 1.4% elimination of CFU was observed, whereas 
after TTP treatment a 74.3  8 24.8% bacterial reduction 
was detected. Both types of antiseptic procedures led to a 
significant reduction in the bacterial colonization (p  ! 
0.05). Moreover, the differences between the groups treat-
ed with octenidine dihydrochloride/2-phenoxyethanol 
solution and TTP were significant (p  ! 0.05). It should be 
noted that the standard deviation calculated from the 
 results in the test fields treated with octenidine dihydro-
chloride/2-phenoxyethanol solution was clearly smaller 
compared to the standard deviation in the TTP-treated 
test sites.
 Influence on the Antioxidative Potential and Skin 
Barrier 
 The concentration of carotenoid antioxidants is given 
in arbitrary units prior to and after treatment with either 
octenidine dihydrochloride/2-phenoxyethanol solution 
or TTP. No differences in the carotenoid concentrations 
before and after treatment with either method were de-
tected (p  1 0.05;  fig. 3 ).
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 Investigation of the Epidermis and Upper Dermis 
Using LSM 
 In  figure 4 , typical images of the skin surface structure 
analyzed by LSM prior ( fig.  4 a) to and following TTP 
( fig. 4 b) and octenidine dihydrochloride/2-phenoxyetha-
nol solution ( fig. 4 c) application are presented. The im-
ages show a smooth skin surface with a clearly recogniz-
able skin structure. A honeycomb corneocyte structure 
prior to and after both treatment methods, correspond-
ing to an intact skin barrier, was found in the skin of all 
volunteers. No signs of inflammation such as dilated 
blood vessels, leukocyte rolling or inflammatory infil-
trate within the epidermis were observed before and after 
both treatments. In none of the 9 volunteers could signs 
of skin damage be observed.
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 Fig. 3. Concentration of carotenoids measured by resonance Ra-
man spectrometry prior to and after treatment using either TTP 
or ODC (octenidine dihydrochloride/2-phenoxyethanol). 
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 Fig. 4. Typical images of the skin surface analyzed by LSM: untreated skin ( a ); TTP treatment ( b ); octenidine dihydrochloride/2-
phenoxyethanol solution treatment ( c ). 
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 Fig. 2. Efficacy of the antisepsis after treatment with ODC (oc-
tenidine dihydrochloride/2-phenoxyethanol solution) and after 
TTP treatment. 
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 Discussion 
 With the increasing emergence of multidrug-resistant 
bacteria, the search for innovative antimicrobial strate-
gies is most important. Apart from chemical antisepsis, 
physical antiseptic procedures seem to be promising tools 
for the antiseptic treatment of living tissue and material, 
since they might be able to eliminate bacteria in hair fol-
licles  [26] . Cold atmospheric plasma is a state of matter 
similar to gas in which a certain portion of the particles 
is ionized  [13] . Due to the presence of a nonnegligible 
number of charged carriers, the plasma becomes electri-
cally conductive; thus, it responds strongly to electro-
magnetic fields. It has been proposed that cold plasma is 
able to destroy bacteria by damaging the microbial DNA 
and surface structures without being harmful to human 
tissues  [13, 15, 27] .
 The aim of our study was to evaluate whether the al-
ready hypothesized effect of TTP on bacterial growth in 
vitro could be reproduced in vivo and to compare the 
bactericidal efficacy of TTP to the clinically well-estab-
lished antiseptic octenidine dihydrochloride/2-phenoxy-
ethanol solution  [28] .
 The results revealed that the number of bacterial colo-
nies on the skin surface was strongly reduced by both 
methods of treatment. Complete elimination of bacteria 
from the test site by octenidine dihydrochloride/2-phe-
noxyethanol solution could be achieved in 5 out of 9 vol-
unteers. For the 4 remaining volunteers, only small num-
bers of CFU per test field were detected after treatment. 
Inadequate antiseptic treatment, as well as a recoloniza-
tion from the follicular orifices, has to be considered to 
be a reason for the incomplete elimination of bacteria 
from the skin.
 TTP treatment can also provide a highly efficient an-
tiseptic effect on the skin surface. The results are in agree-
ment with the data presented in different studies, in 
which a significant reduction of the bacterial load after 
plasma treatment was reported  [12, 14, 15, 17, 26] . Lade-
mann et al.  [17] suggested that the main reason for the 
antiseptic efficacy might be the formation of free radicals 
in the plasma-tissue interaction zone. Additionally, syn-
ergistic effects with the TTP-related UV irradiation and 
the slight temperature increase have to be discussed. Re-
cently, the highly efficient antiseptic effect of the plasma 
on Gram-positive and Gram-negative bacteria, biofilm-
producing bacteria, viruses, fungi and spores has been 
reported  [10] . Advantages of plasma treatment are that 
bacteria cannot develop a resistance to the plasma  [10] 
and that plasma treatment does not evoke allergies or tox-
ic reactions as reported for conventional antiseptics, since 
plasma treatment is a physical antiseptic process.
 Recently, it has been reported that plasma can also re-
duce the bacterial load in hair follicles and in this regard 
might actually be superior to liquid antiseptics. Lange-
Asschenfeldt et al.  [29] showed that hair follicles are an 
efficient reservoir for bacteria. Once successfully treated 
with local antiseptics, the skin surface is recolonized by 
bacteria and fungi, which are conveyed with the sebum 
onto the skin surface. Most topically applied liquid sub-
stances only reach the follicular orifices, but do not pen-
etrate into the deeper regions of the hair follicle  [19, 
26, 30] . Consequently, the efficacy of plasma treatment 
should be superior or at least equal to that of liquid anti-
septics. The results of the present study show, however, 
that plasma has a slightly reduced efficacy compared to 
octenidine dihydrochloride/2-phenoxyethanol solution.
 One might speculate that one reason for this phenom-
enon may be the difficulty to scan a skin area of 4  ! 4 
cm manually with a thin plasma beam without leaving 
isolated ‘islands’ void of plasma-tissue interaction. This 
limitation for the plasma jet application can be easily 
overcome by enlarging the plasma beam to a diameter of 
5–10 mm, or by the introduction of technical scanning 
devices as already used in therapeutic laser devices.
 Fluhr et al.  [31] demonstrated the formation of free 
radicals on the skin surface and in the hair follicles dur-
ing the plasma treatment. Increased levels of free radicals 
normally lead to a decrease in antioxidants due to neu-
tralization of the free radicals. In the present study, how-
ever, no changes in the carotenoid concentration, which 
is one of the major antioxidants in the skin, could be de-
tected after treatment with both methods. This discrep-
ancy can be explained by the fact that in the present study 
resonance Raman spectroscopic measurements were ap-
plied where a tissue volume of 8 mm in diameter and ap-
proximately 150   m in depth was integrally analyzed. 
Thus, the measurements of the carotenoid concentration 
under the present study confirm that the radical forma-
tion is restricted exclusively to the skin surface and the 
uppermost layers of the stratum corneum, i.e. the effect 
of the plasma is restricted to those dermal structures, 
which accommodate the bacterial colonies.
 Another indication for the tissue tolerability of TTP is 
that the properties of the skin barrier remain unchanged 
as demonstrated by the LSM analysis. In case of irritation 
of the skin by the antiseptic procedures, LSM features 
similar to acute dermatitis, including spongiosis, exocy-
tosis, vesicle formation and blood vessel dilation as well 
as disruption of the stratum corneum and epidermal ne-
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crosis  [32] , could be expected. However, in the present 
study no signs of alteration of the skin as studied by LSM 
were found after using both antiseptic procedures.
 In summary, it can be stated that plasma treatment of 
the skin may be a promising alternative to skin antisepsis 
using liquid antiseptics. The lower efficacy of plasma 
treatment compared to the treatment with liquid antisep-
tics might be attributed to current technical limitations 
of the used prototypes that have already been overcome 
by newer devices. For locally restricted treatments (e.g. in 
dentistry) a plasma jet with a thin plasma beam may be 
particularly suited. However, large skin areas should be 
treated with plasma beams with larger diameters (prefer-
ably 5–10 mm) or scanning devices, which ensure com-
plete coverage of the treated area.
 The present study shows that TTP treatment is con-
centrating its efficacy on the uppermost layers of the stra-
tum corneum and the first cell layers of the corneocytes 
without harming the treated skin.
 An advantage of TTP treatment is that it obviously ex-
erts antiseptic effects on the hair follicles, where liquid 
antiseptics show only limited efficacy. The investigations 
described herein are of preliminary nature. At the present 
time, the observed results cannot be transferred 1:  1 to 
chronic wounds as the individuals included in the study 
were healthy volunteers. Therefore, further studies are 
necessary to evaluate the capabilities of TTP on skin dis-
eases and wounds. Time will show whether TTP will gain 
comparable importance as in the case of medical laser 
technology today.
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